Skip to content

Evaluating the NeoTree in Malawi and Zimbabwe

Evaluating the NeoTree: An eHealth Solution to Reduce Neonatal Mortality in Two Low Income Countries: Malawi and Zimbabwe

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05127070
Enrollment
19000
Registered
2021-11-19
Start date
2019-10-01
Completion date
2022-09-01
Last updated
2022-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal Death, Neonatal Disorder, Neonatal Encephalopathy, Neonatal Hypoglycemia, Neonatal Hypothermia, Neonatal Jaundice, Neonatal Respiratory Failure, Neonatal Seizure, Neonatal Sepsis, Prematurity

Brief summary

Neonatal mortality remains unacceptably high. Globally, the majority of mothers now deliver in health facilities in low resource settings where quality of newborn care is poor. Health systems strengthening through digitial quality improvement systems, such as the Neotree, are a potential solution. The overarching aim of this study is to complete the co-development of NeoTree-gamma with key functionalities configured, operationalised, tested and ready for large scale roll out across low resource settings. Specific study objectives are as follows: 1. To further develop and test the NeoTree at tertiary facilities in Malawi and Zimbabwe 2. To investigate HCPs and parent/carer view of the NeoTree, including how acceptable and usable HCWs find the app, and potential barriers and enablers to implementing/using it in practice. 3. To collect outcome data for newborns from representative sites where NeoTree is not implemented. 4. To test the clinical validity of key NeoTree diagnostic algorithms, e.g. neonatal sepsis and hypoxic ischaemic encephalopathy (HIE) against gold standard or best available standard diagnoses. 5. To add dashboards and data linkage to the functionality of the NeoTree 6. To develop and test proof of concept for communicating daily electronic medical records (EMR) using NeoTree 7. To initiate a multi-country network of newborn health care workers, policy makers and academics. 8. To estimate cost of implementing NeoTree at all sites and potential costs at scale

Detailed description

Every year 2.4 million newborn deaths occur worldwide. Up to 70% of newborn deaths are avoidable with implementation of standard-technology, evidence-based interventions. Health systems strengthening and education and training in newborn care are key to saving newborn lives. Implementation of evidence based interventions and guidelines can be supported through provision of reliable data systems, clinical decision support tools and education. Using open-source code and maintaining local data ownership the investigators have used iterative, human- and user-centered design methods and agile processes in software and data management development and design to develop the Neotree: a digital quality improvement system for postnatal facility-based care in low resource settings. The Neotree aims to improve quality of care and newborn survival through combining data-capture, clinical decision-support, education in newborn care, and feedback of data to dashboards and national aggregate data systems. The investigators found the concept of device-enabled decision support to improve newborn care to be acceptable during workshops with healthcare professionals in Bangladesh (n\ 15; 2014) and developed and delivered a prototype of the app. Following this, the investigators co-developed and piloted an early version of the NeoTree with Malawian Healthcare Professionals (HCPs) (n=46; 2016-2017), who reported it was easy to use and helped them deliver quality care. The research project described in this protocol will enable the investigators to complete the co-development of the Neotree in Zimbabwe and Malawi and generate evidence for how to test it at scale. Methods and analysis: Mixed methods (i) intervention co-development and optimisation, (ii) pilot implementation evaluation and (iii) economic evaluation study. The Neotree will be implemented in two hospitals in Zimbabwe, and one in Malawi. Clinical and demographic newborn data will be collected via the Neotree, in addition to behavioural science informed qualitative and quantitative implementation evaluation data, cost data, measures of quality newborn care and usability data over the 2-year study period. Six-months of newborn outcome data and cost data will be collected from 2 hospitals receiving usual care for comparison. Case-fatality rate data will inform sample size calculations and study design for a large scale roll out. Training manuals will be refined. Neotree clinical decision support algorithms will be optimised according to best available evidence and clinical validation studies. Our overall vision is to use best practice and information technology to improve clinical decisions for newborn care and increase rates of newborn survival in under-resourced health care settings. In this study, the care for an estimated 15,000 babies across the three test sites will be impacted by the Neotree. Through successful rollout across Zimbabwe and Malawi - the care for nearly 300,000 babies could be improved annually.

Interventions

DEVICENeotree

The Neotree is a digital app, data collection and quality improvement system. collecting and collating routine health data at the bedside for babies on admission and discharge and for laboratory results. it provides point of care education and clinical decision support to optimise the clinical care of sick and vulnerable newborns according to approved and best available clinical guidelines.

Sponsors

Biomedical Research and Training Institute, Zimbabwe
CollaboratorOTHER
PACHI Malawi - Parent and Child Health Initiative Trust
CollaboratorOTHER
Ministry of Health and Child Welfare, Zimbabwe
CollaboratorOTHER
University College, London
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL

Inclusion criteria

Group 1: Healthcare professionals w HCP will be recruited to the behaviour change and implementation science evaluation study at SMCH, KCH and CPH. Qualitative and quantitative methods will assess acceptability, feasibility and usability of the NeoTree. We estimate a sample size of 160 across sites addressing each aspect, and will carry out an assessment for data thematic saturation before conducting any further interviews (Sample size \ 160). An additional 30 HCPs will be recruited to the health economic cost data. Inclusion criteria: * working as a healthcare professional or manager caring for newborns admitted to SMCH, KCH or CPH newborn care units during the study period * Willing and able to give written or audio informed consent for participation.

Exclusion criteria

● aged over 65 years (Zimbabwe only); No upper exclusion age in Malawi Group 2: Parents/ carers A qualitative study will be conducted with families and carers of newborns admitted to the intervention hospitals to assess acceptability of the NeoTree (Sample size \ 30, followed by analysis for thematic saturation prior to carrying out further interviews). Inclusion criteria: * Parent/carer of a live newborn requiring admission to SMCH, KCH or CPH newborn care units during the study period * Willing and able to give written or audio informed consent for participation.

Design outcomes

Primary

MeasureTime frameDescription
Acceptability of the Neotree as a digital tool to improve neonatal care and survival using the Theoretical framework of acceptability (TFA) among newborn health care providers and parents/ families of sick/ vulnerable newborns.2.5 yearsQualitative data collected via semi-structured interviews and focus groups will be collected. Topic guides will be informed by the TFA in order to assess acceptability of the Neotree to be embedded into usual clinical care to improve care and outcomes for sick and vulnerable babies in low resource settings.
Feasibility of the Neotree as a digital tool to improve neonatal care and survival using the Theoretical domains framework (TDF) of feasibility among newborn health care providers and parents/ families of sick/ vulnerable newborns.2.5 yearsmplementation science evaluation of feasibility of the Neotree to be embedded into Qualitative data collected via semi-structured interviews and focus groups will be collected. Topic guides will be informed by the TDF in order to assess feasibility of the Neotree to be embedded into usual clinical care to improve care and outcomes for sick and vulnerable babies in low resource settings.
Quantitative Usability (Systems usability score) and qualitative usability of the Neotree and usage (percentage of admitted babies with Neotree admissions data) of the Neotree2.5 yearsmplementation science evaluation of usability and usage of the Neotree to be for healthcare workers in low resource hospital settings in Malawi and Zimbabwe to optimise quality of care or newborns.

Secondary

MeasureTime frameDescription
Measures of quality of newborn care (aligned with WHO standards of quality newborn care)2.5 yearsQuantiative measures of standards of quality newborn care measured using the Neotree data. in the 3 hospital facilities where it is implemented.
Cost of implementation2.5 yearsCosts of implementation of the Neotree to 3 newborn care units, 2 in Zimbabwe and 1 in Malawi
5. number of babies with key diagnoses over time (e.g. prematurity, neonatal sepsis, neonatal encephalopathy)2.5 yearsNumber and outcome (death/discharge) for key diagnostic groups
Case fatality rates (deaths per 1000 babies admitted to newborn care unit) over time2.5 yearsCase fatality rates of admitted babies to the 3 hospital units using the Neotree over time
Facility based neonatal mortality and stillbirth birth rates overtime1.5 yearsOverall deaths per 1000 live births and still birth rates in the 3 hospital units using the Neotree over time.

Countries

Malawi, Zimbabwe

Contacts

Primary ContactMichelle Heys, MD(Res)
m.heys@ucl.ac.uk07541381106

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026